The opportunity to remove silos and work towards more efficient solutions and processes is one of the key challenges in harnessing the potential of RBQM. DGE invites the top clinical industry professionals working in this dedicated field to learn from the leading industry experts. They will discuss the details of executing audit trails, data flow process maps, quality tolerance limits, and data monitoring tools.
The clinical trial landscape has dynamically changed post COVID-19, with quality risk management tools and techniques evolving over the years. The 3rd Risk Based Quality Management Summit will share best practices in RBQM to influence clinical study methodology and decentralized trials, focusing on centralized monitoring and risk-based data review.
To learn more, please visit https://ibn.fm/FYNr4.